TCG Crossover GP II, LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-15
4:20 pm
Purchase
2024-02-1213GMINERALYS THERAPEUTICS INC
MLYS
TCG Crossover GP II, LLC3,185,185
6.400%
3,185,185increase
(New Position)
Filing
History
2024-02-15
4:17 pm
Purchase
2024-02-0813GADVERUM BIOTECHNOLOGIES INC CO
ADVM
TCG Crossover GP II, LLC2,076,357
9.900%
2,076,357increase
(New Position)
Filing
History
2024-01-16
4:18 pm
Purchase
2024-01-0513GASTRIA THERAPEUTICS INC
ATXS
TCG Crossover GP II, LLC4,368,928
9.900%
4,368,928increase
(New Position)
Filing
History
2023-10-16
4:37 pm
Purchase
2023-10-0413GVISTAGEN THERAPEUTICS INC
VTGN
TCG Crossover GP II, LLC2,702,157
9.900%
2,702,157increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2